# BioLineRx Ltd. (BLRX)

> Healthcare · IL · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/BLRX/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 477.0K | $ -2.58M | $ -2.29M | $ 9.07M | $ 16.67M |
| 2025 | $ 1.21M | $ -1.21M | $ -8.32M | $ 10.15M | $ 18.20M |
| 2024 | $ 30.42M | $ -9.69M | $ -46.17M | $ 15.04M | $ 13.46M |
| 2023 | $ 5.19M | $ -65.54M | $ -24.77M | $ 11.59M | $ 13.22M |
| 2022 | $ 0 | $ -27.87M | $ -29.67M | $ 12.32M | $ 50.84M |
| 2021 | $ 0 | $ -32.16M | $ -28.14M | $ 4.65M | $ 68.09M |
| 2020 | $ 0 | $ -38.24M | $ -29.56M | $ 7.68M | $ 22.03M |
| 2019 | $ 0 | $ -32.84M | $ -29.35M | $ 10.46M | $ 33.38M |
| 2018 | $ 0 | $ -30.33M | $ -45.44M | $ 8.73M | $ 41.32M |
| 2017 | $ 0 | $ -32.81M | $ -33.39M | $ 250.0K | $ 52.88M |
| 2016 | $ 0 | $ -21.80M | $ -20.04M | $ 343.0K | $ 35.03M |
| 2015 | $ 0 | $ -20.22M | $ -23.71M | $ 437.0K | $ 47.61M |
| 2014 | $ 0 | $ -14.89M | $ -20.71M | $ 0 | $ 31.77M |
| 2013 | $ 0 | $ -24.83M | $ -28.94M | $ 0 | $ 11.68M |
| 2012 | $ 0 | $ -29.90M | $ -29.29M | $ 36.7K | $ 14.97M |
| 2011 | $ 0 | $ -20.29M | $ -16.91M | $ 109.6K | $ 22.53M |
| 2010 | $ 48.29M | $ 3.93M | $ 16.36M | N/A | N/A |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.54 |
| Liabilities / Eq | 1.08 |
| Current Ratio | 1.58 |

## Other views

- [Metrics](https://sponda.capital/en/BLRX.md)
- [Charts](https://sponda.capital/en/BLRX/charts.md)
- [Compare](https://sponda.capital/en/BLRX/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-27.